Search / Trial NCT06612528

Transcranial Direct Current Stimulation on Singer's Voice

Launched by UNIVERSIDADE FEDERAL DE PERNAMBUCO · Sep 21, 2024

Trial Information

Current as of October 08, 2024

Enrolling by invitation

Keywords

Transcranial Direct Current Stimulation T Dcs Flexible Tube Voice Singers

Description

Data collection is being conducted at the Applied Neuroscience Laboratory (LANA) of the Federal University of Pernambuco (UFPE). Videolaryngoscopy is performed at the UFPE Hospital, in the laryngology outpatient clinic. This phase of the study includes vocally healthy individuals who are singers without formal music or singing training. Residents of the city of Recife and the Metropolitan Region, aged 18 to 45 years. The age range was chosen considering the period of maximum vocal efficiency To determine the sample size, in phase 2, a pilot study was conducted with 15 participants that wil...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Vocally healthy singers without formal singing education
  • Exclusion Criteria:
  • * Participants will be excluded from the sample if they were smokers, had abnormalities in previous otorhinolaryngological examination, or exhibited signs and symptoms of laryngeal, pharyngeal, or respiratory diseases at the time of collection. Volunteers who regularly used neuroactive medications, had metallic implants in the cervical region or above, or had any history of seizures or epilepsy will also be excluded.

About Universidade Federal De Pernambuco

Universidade Federal de Pernambuco (UFPE) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health sciences. As a clinical trial sponsor, UFPE leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving healthcare outcomes. The university is dedicated to ethical research practices and collaborates with a diverse array of institutions and stakeholders to facilitate the development of new therapies and interventions, ultimately contributing to the enhancement of public health both locally and globally.

Locations

Recife, Pernambuco, Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0